Inverna Therapeutics develops an RNA therapeutics platform to modify RNA expression with unparalleled specificity. Leveraging sequence-specific activation of pseudo exons, we develop safer, more effective precision medicines for unmet medical needs.
Spin-out in 2021
Praemostro originated from a research project at Odense University Hospital. Today, we are an independent company helping you optimize resources and create a more stable daily workflow.